Europe rethinks patent on the Harvard mouse

October 1991
New Scientist;10/19/91, Vol. 132 Issue 1791, p11
Reports on the decision of the European Patent Office (EPO) that Harvard University's 'onco-mouse' can be patented in Europe. Reason behind the reversal of the previous decision of the EPO; Impact of the move on the biotechnology industry; Argument that technologies cannot be excluded en bloc from patent protection risks.


Related Articles

  • Festo: A patent applicant's plague. Brown, Scott M.; Familant, Scott B. // Journal of Commercial Biotechnology;Spring2001, Vol. 7 Issue 4, p329 

    This paper highlights some of the intricacies and complexities associated with patent drafting, particularly in unpredictable sciences such as biotechnology. The paper draws on the new guidelines issued by the Patent Office regarding compliance with the 'utility' and 'written description'...

  • Conceptions of property and the biotechnology debate. Thompson, Paul B. // BioScience;Apr95, Vol. 45 Issue 4, p275 

    Reviews the philosophical approaches of the conceptions of property and the biotechnological debate associated with it. Instrumental conceptions of property; Ontological conceptions of property; Assessment of the biotechnology debate.

  • Italian government rebuffs emerging biotechnology industry. Ballmaier, Martina // Nature Medicine;Apr99, Vol. 5 Issue 4, p363 

    Reports on the Italian government's complaint about the European Union directive on patenting biotechnological inventions. Number of Italian scientists involved in biotechnology; Number of patents filed by the scientists; Patenting of isolated human genes.

  • Unequal voice.  // New Internationalist;Sep2002, Issue 349, p19 

    Reports on the underrepresentation of developing countries in international negotiations for patents on biological development. Costs of patenting; Expensiveness of challenging biopiracy.

  • Europe to update bio-patent laws. Milmo, Sean // Chemical Market Reporter;07/21/97, Vol. 252 Issue 3, p7 

    Reports that the European Parliament has voted in favor of a directive on patents for biotechnology inventions.

  • Patented protection. Gopal, Kevin // Pharmaceutical Executive;Jun98, Vol. 18 Issue 6, p38 

    Reports on the passage of the European Union directive concerning the legal protection of biotechnological inventions. What the directive includes; Comment from German Willi Rothley, a Social Democrat who proposed the directive; Reaction from the European Federation of Pharmaceutical Industries...

  • A biotech roadblock. Hager, Mary; Rogers, Adam // Newsweek;4/13/1998, Vol. 131 Issue 15, p66 

    Focuses on the patent application of Stuart Newman, a cell biologist at the New York Medical College in New York. The patent being on ways to make human-animal chimeras; The reason for not wanting human DNA as an ingredient in biotechnology; Comments from Newman and Jeremy Rifkin, head of the...

  • In Brief. J.F.; A.M.; A.B. // Nature Biotechnology;Jul2001, Vol. 19 Issue 7, p607 

    Presents several business and regulatory news articles related to biotechnology as of July 2001. Tabulation of the U.S. Agroterrorism Prevention Act of 2001; Multi-million dollars worth of venture capital raised by European biotechnology companies; Patent held by Nutley, New Jersey-based...

  • Engineering a Euro mess.  // New Scientist;5/14/94, Vol. 142 Issue 1925, p3 

    Opinion. Discusses the need for establishing standards for patenting biotechnology inventions in the European Union. Ethical and economic implications of patenting human body parts and altered animals; Directive of the European Commission on indiscriminate awarding of patents; Procedural...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics